|
Compound class:
Synthetic organic
Comment: This molecule is a heterobifunctional PROTAC designed for targeted degradation of the histone lysine methyltransferase NSD2 [1]. It promotes formation of a ternary complex with NSD2 and the E3 ubiquitin ligase FBXO22, and NSD2 degradation by the ubiquitin protein ligase complex. NSD2 degradation is proposed as an anti-tumour mechanism.
The FBXO22-recruiting warhead has also been conjugated to a validated CDK12-binding scaffold to demonstrate the potential of FBXO22 for PROTAC design beyond NSD2. |
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| The DC50 for T9 PROTAC-mediated NSD2 degradation is 370 nM, and the Dmax is ~92% [1]. |
| Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||